Clinical Trials Logo

Clinical Trial Summary

This study investigated the impact of highest drain fluid amylase (DFA) level on postoperative pancreatic fistula (POPF) severity and outcomes of patients undergoing pancreaticoduodenectomy (PD) with POPF. Patient demographics of biochemical POPF and clinically relevant POPF (CR-POPF) were compared. Predictive factors were assessed using binary logistic regression. Receiver operating characteristic curve analysis was performed to determine the optimal cutoff value of highest DFA (beyond 3 days post-PD). The investigators compared length of hospital stay, surgical mortality rates, and need for postoperative interventions by highest DFA level.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04448795
Study type Observational
Source Chang Gung Memorial Hospital
Contact
Status Completed
Phase
Start date October 1, 2010
Completion date May 30, 2020

See also
  Status Clinical Trial Phase
Completed NCT03627559 - Early Detection of Anastomotic Leakage by Microdialysis Catheters
Completed NCT06227871 - A Retrospective Analysis of Pancreatic Injuries and Treatment Outcomes
Recruiting NCT05518643 - Compliance With ERAS Protocol in Pancreatic Surgery, Stress Response and Outcomes
Recruiting NCT04402346 - Radiofrequency-assisted Transection of the Pancreas vs Stapler N/A
Recruiting NCT04274972 - The Microbiome of Pancreatic Cancer: "PANDEMIC" Study
Completed NCT03410914 - Intra-operative Application of HEMOPATCH to the Pancreatic Stump to Prevent Post-operative Pancreatic Fistula Following Distal Pancreatectomy Phase 2